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Abstract
The aim of this study was to determine the expression of constitutive NO synthases (ecNOS and bNOS) at the protein level
in rat and human gastrointestinal tract. We established a quantitative Western blotting method for detection and
quantification of ecNOS and bNOS in both species. Human gastric fundus was further analyzed by immunohistochemistry.
EcNOS expression at the protein level could be quantified in different organs of the rat gastrointestinal tract and in human
gastric mucosal biopsies. Immunohistochemistry of gastric fundus revealed that immunoreactivity for ecNOS was localized
mainly in the endothelium of small vessels. In rats, expression of bNOS at the protein level was highest in esophagus. By
means of immunohistochemistry of human gastric fundus, immunoreactivity was detected mainly in the plexus of Auerbach.
We conclude that isoforms of constitutive nitric oxide synthase can be identified and quantified at the protein level both in
rat and human gastrointestinal tract. The presence of bNOS in nerve tissue supports previous observations that NO serves as
a transmitter in non-adrenergic, non-cholinergic nerves in human esophagus and stomach. The observation that ecNOS has
been found mainly in endothelial cells suggests the involvement of NO in the regulation of mucosal blood flow. ß 1999
Elsevier Science B.V. All rights reserved.
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1. Introduction
In 1987 it was demonstrated that vascular endo-
thelial cells could synthesize nitric oxide (NO), which
reacts as a labile messenger of short half-time that
relaxes vascular smooth muscle [1]. NO synthase (EC
1.14.13.39) catalyzes NO formation from the termi-
nal guanidino-nitrogen of L-arginine [2]. Up to now
three isoforms have been identi¢ed, that serve vari-
ous functions. Two of them, the endothelial cell-de-
rived NO synthase (ecNOS, NOS III) and the brain
NOS isoform (bNOS, NOS I), are constitutively ex-
pressed in various tissues and synthesize small
amounts of NO. The third isoform, inducible NO
synthase (iNOS, NOS II) is calcium-independent
and is induced in various cell types (macrophages,
neutrophils, hepatocytes, endothelial cells and vascu-
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lar smooth muscle cells) upon stimulation with cyto-
kines and bacterial endotoxins [3,4].
The role of NO in gastric physiology and patho-
physiology has not been fully elucidated. Using the
L-arginine/citrulline assay, Salter et al. reported high
NOS activity in rat stomach, which was mainly cal-
cium-dependent and hence should represent constit-
utive NO synthase [5].
Using immunohistochemistry and by means of NO
synthase inhibitors, there is increasing evidence that
bNOS ^ possibly in cooperation with vasoactive in-
testinal peptide (VIP) ^ might play a key role in non-
adrenergic non-cholinergic innervation of the eso-
phagus controlling esophageal motility and pressure
of the lower esophageal sphincter (LES) and is in-
volved in receptive relaxation of the gastric fundus
[6^10]. Furthermore, although discussed contro-
versially, there is evidence that gastric emptying in
humans can be diminished by NO donors [11,12]. We
have shown recently that it can be accelerated by
NOS blockade [13]. Functional and morphological
studies suggest a role for NOS in gastroprotection,
possibly due to improved microcirculation [14,15].
Mere measurement of NOS enzyme activity cannot
discriminate between ecNOS and bNOS. Immuno-
histochemistry detects di¡erent NOS expression
only on a semiquantitative level. Hence, we tried to
identify and measure more quantitatively the di¡er-
ent NOS isoforms at the protein level. In this study,
we developed a Western blot technique for quantita-
tive measurement of NOS at the protein level in the
gastrointestinal (GI) tract. We were able to detect
ecNOS and bNOS in di¡erent rat tissues. Further-
more, we analyzed bNOS and ecNOS in biopsies and
surgical specimens of human gastric mucosa and
smooth muscle by Western blot and by immunohis-
tochemistry.
2. Materials and methods
2.1. Animals
Male Wistar rats (body weight 200^300 g) which
had fasted overnight were killed. Organs (full thick-
ness samples, muscle plus mucosa, serosa had been
removed) were prepared and immediately frozen in
liquid nitrogen.
2.2. Subjects
For quanti¢cation of NOS expression in human
upper GI tract, eight healthy volunteers (3 males,
5 females) between the ages of 23 and 35 years and
weighing 54 to 82 kg participated in the study. None
of them had a history of gastrointestinal disease or
complained of any symptom of a gastrointestinal
disease. All subjects underwent [13C]urea breath test
to exclude infection with Helicobacter pylori. Stand-
ard unsedated upper endoscopy was performed, and
biopsies of esophagus and stomach (corpus and
antrum) were taken and immediately frozen in liquid
nitrogen.
2.3. Patients
Tissue samples of human gastric fundus were col-
lected from surgical resections. Normal gastric and
esophageal tissue was obtained from macroscopically
and histologically normal stomach of ¢ve patients
(3 men, 2 women, age range 52^79 years) undergoing
esophageal resection because of esophageal carcino-
ma. Immediately after resection the tissue was cooled
in pre-oxygenated Tyrode’s solution and dissected
into mucosal and smooth muscle layer, followed by
freezing in liquid nitrogen.
The study had been approved by the local Ethical
Committee, and all subjects gave written informed
consent.
2.3.1. Sodium dodecyl sulfate^polyacrylamide gel
electrophoresis (SDS^PAGE) and Western
blot analysis of bNOS and ecNOS
Samples were homogenized in 10 mmol NaCO3/
3% SDS using a microdismembrator (Braun, Mel-
sungen, Germany). Equal amounts of protein were
loaded onto 7.5% SDS polyacrylamide gels. After
electrophoresis which was performed according to
the method of Laemmli [16], the separated proteins
were transferred onto nitrocellulose membranes
(Schleicher and Schu«ll, Dassel, Germany) as de-
scribed previously [17]. After transfer the nitrocellu-
lose membranes were stained with Ponceau’s staining
solution and scanned densitometrically. As the ¢rst
antibody we used a mouse bNOS monoclonal anti-
body and a mouse monoclonal ecNOS antibody (Af-
¢niti, Mamhead, UK). As a second antibody, the
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membranes were probed with 125I-labeled protein A
or anti-mouse IgG, respectively. Visualization and
quanti¢cation was performed with a Phospho Imager
system (Molecular Dynamics, Krefeld, Germany).
Protein loading di¡erences were corrected for by
densitometric quanti¢cation of Ponceau staining.
Comparison of the results with and without consid-
ering loading di¡erences revealed no principally dif-
ferent results, but smaller S.E.M. values if correction
for Poinceau staining was made. A reference sample
(‘poolmix’) of bovine aortic endothelium (for ec-
NOS) or of recombinant bNOS protein (for
bNOS), respectively, were run on every gel which
allowed to correct for di¡erent blotting e⁄ciency.
2.4. Immunohistochemistry
For immunohistochemistry, cryostat fresh frozen
7-Wm sections were ¢xed for 10 min in cold acetone,
air-dried and immunostained. The ¢rst antibodies
(anti ecNOS and anti bNOS polyclonal antibody,
Fig. 1. Expression and quanti¢cation of bNOS in homogenates
from rat esophagus. (Upper panel) Autoradiogram of Western
blot of bNOS in rat esophagus at di¡erent amounts of protein
loaded per lane of gel. CTR, rat recombinant neuronal NO
synthase (0.25 Wg). (Lower panel) Protein dependence between
25 and 125 Wg (mean þ S.E.M., n = 6). Abscissa: amount of pro-
tein loaded (Wg); ordinate: pixels (arbitrary PhosphorImager
units) of bNOS quanti¢cation.
Fig. 2. Expression and quanti¢cation of bNOS in homogenates
of di¡erent rat organs. (Upper panel) Autoradiogram of West-
ern blot of di¡erent tissues. (Lower panel) Quanti¢cation of
bNOS protein expression in the rat gastrointestinal tract
(mean þ S.E.M., n = 6). E, eso-phagus (100 Wg); S, stomach (100
Wg); I, ileum (100 Wg); C, colon (100 Wg); CR, cerebellum (25
Wg); CTR, recombinant bNOS protein (0.25 Wg). Abscissa: tis-
sue; ordinate: pixels (arbitrary PhosphorImager units) of bNOS
quanti¢cation.
Fig. 3. Expression of bNOS in homogenates from human
esophagus and stomach (crude preparations of surgical speci-
mens from patients undergoing esophageal resection: fundic
mucosa and smooth muscle) and mucosal biopsies from healthy
volunteers (200 Wg protein per lane). Autoradiogram of Western
blot of di¡erent tissues. MB, biopsy of human gastric mucosa;
MS, surgical specimen of human gastric mucosa; ES, human
esophagus; SSM, fundic smooth muscle of human stomach;
bNOS, recombinant bNOS protein (0.25 Wg).
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A⁄niti) were diluted 1:100 and incubated with cry-
osections of the tissue at room temperature. The re-
action was completed with alkaline phosphatase anti-
alkaline phosphatase kit (Dako, Copenhagen, Den-
mark) using Fast red as a chromogen.
2.5. Statistics
Results are expressed as means þ S.E.M. The sig-
ni¢cance of di¡erences was evaluated by ANOVA
testing and t-test with Bonferroni’s correction.
3. Results
3.1. bNOS expression in rat and human alimentary
tract
Using a monoclonal antibody, a protein tenta-
tively identi¢ed as bNOS protein was detectable as
a single band of about 160 kDa (Fig. 1). The appar-
ent molecular mass of the detected signal was sim-
ilar in size to the signal in a homogenate of rat cer-
ebellum used as an abundant source of bNOS and to
the signal of recombinant rat neuronal bNOS (Figs.
1 and 2). In esophageal homogenates this band was
proportional to the amount of protein loaded in a
range between 25 and 125 Wg protein (Fig. 1). Thus,
100 Wg was used in subsequent experiments. The
bNOS signal was detectable in stomach, esophagus,
ileum and colon of the rat (Fig. 2, top). Quantitative
determination of the bNOS signal in the rat gastro-
intestinal tract revealed highest values in the eso-
phagus (0.34 þ 0.01U106 arbitrary units), while
stomach (0.10 þ 0.01U106 arbitrary units), colon
(0.14 þ 0.01U106 arbitrary units) and ileum
(0.04 þ 0.01U106 arbitrary units) exhibited signi¢-
cantly lower signals (Fig. 2, bottom). In biopsies
and surgical resection specimens of human esopha-
gus and human stomach it was also possible to ob-
tain a signal of apparent molecular mass similar to
the signal of recombinant rat neuronal bNOS pro-
tein. This signal was found in crude preparations of
surgical specimen (fundic mucosa and smooth
muscle, esophagus) which were derived from histo-
logically and macroscopically uninvolved tissue of
patients undergoing esophageal resection and in mu-
cosal biopsies (stomach and esophagus) from healthy
volunteers (Fig. 3). Immunohistochemistry for bNOS
in the human fundic wall revealed positive immuno-
reactivity only in the neural elements and not in the
nerve endings or the nerves supplying the vessels.
Fig. 4. Immunohistochemical detection of bNOS in the fundus of human stomach. Photograph of alkaline phosphatase-stained frozen
section. Magni¢cation: U400.
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Muscle cells of the muscularis propria did not ex-
press bNOS (Fig. 4).
3.2. ecNOS expression in rat and human alimentary
tract
Employing a monoclonal antibody against ecNOS
protein, a single band of about 140 kDa was detect-
able in esophagus, stomach, colon and ileum of the
rat (Fig. 5A). The apparent molecular mass of the
detected signal was similar to the signal in a homo-
genate of bovine endothelial cells (Fig. 5A). The sig-
nal was proportional to the amount of loaded pro-
tein in a range between 100 and 200 Wg protein (Fig.
5B). Thus, 150 Wg was used in subsequent experi-
ments. Quanti¢cation of the signal revealed nearly
identical values in rat esophagus (0.13Uþ 0.02U106
arbitrary units), rat stomach (0.14 þ 0.02U106 arbi-
trary units) and rat colon (0.17 þ 0.04U106 arbitrary
units), while rat ileum homogenates contained signif-
icantly smaller amounts of ecNOS protein
(0.04 þ 0.02U106 arbitrary units) (Fig. 6). We also
detected and quanti¢ed ecNOS protein in human
gastric mucosal biopsies of healthy volunteers. Val-
ues were higher in antrum (0.15 þ 0.03U106 arbitrary
units) than in corpus (0.1 þ 0.02U106 arbitrary units)
(Fig. 7). Immunoreactivity positive for ecNOS was
visible in the arteries and veins of human gastric
wall. The signal was located mainly in endothelial
cells (Fig. 8).
4. Discussion
Recently, a role for ecNOS in hepatic gastropathy
was described in a rat animal model [18,19]. In
esophageal specimens of portal hypertensive rats ec-
NOS expression was found to be enhanced as meas-
ured by immunohistochemistry and reverse transcrip-
Fig. 6. Quanti¢cation of ecNOS at the protein level in di¡erent
organs of the rat gastrointestinal tract (mean þ S.E.M., n = 6).
E, rat esophagus; S, rat stomach; I, rat ileum; C, rat colon
(150 Wg of protein loaded); BE, bovine endothelial cells (posi-
tive control, 20 Wg). Abscissa: tissue; ordinate: pixels (arbitrary
PhosphorImager units) of ecNOS quanti¢cation.
Fig. 5. Expression of ecNOS in di¡erent rat tissues at the pro-
tein level. (A) Autoradiogram of Western blot of di¡erent tis-
sues. (B) Protein in rat esophagus in a range between 100 and
200 Wg of protein loaded per lane of gel (mean þ S.E.M., n = 6).
CR, rat cerebellum; A, rat aorta; S, rat stomach; I, rat ileum
(150 Wg of protein loaded); BE, bovine endothelial cells (posi-
tive control, 20 Wg). Abscissa: amount of protein loaded (Wg);
ordinate: pixels (arbitrary PhosphorImager units) of ecNOS
quanti¢cation.
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tion^polymerase chain reaction [19]. Further analysis
of this animal model by immunohistochemistry,
Western blot, Northern blot and determination of
enzyme activity in gastric samples also revealed in-
creased expression of ecNOS in this tissue [18]. In
these rats increased gastric mucosal blood £ow and
increased susceptibility to ethanol-induced necrosis
could be normalized by the NOS blocker L-NAME
[18]. Likewise, altered bNOS expression has been as-
sociated with diseased states. Mearin et al. reported a
lack of NO synthase activity and reduced immuno-
histological expression of bNOS in patients su¡ering
from achalasia [20], a disease of esophageal motility
that is characterized by elevated pressure of the lower
esophageal sphincter and simultaneous contractions
of the esophageal body leading to impaired swallow-
ing. However, the authors did not analyze bNOS
expression at the protein level. Infantile pylorus
stenosis was found to be accompanied by a reduction
of NO synthase activity [21]. Moreover, a role of
bNOS in pyloric function is supported by the fact
that bNOS-de¢cient knock-out mice have an abnor-
mally enlarged stomach, which might be due to the
pivotal role of bNOS for pyloric relaxation [22].
Thus, the aim of the present study was to establish
a reliable methodology for detection and quanti¢ca-
Fig. 7. Detection and quanti¢cation of ecNOS in mucosal biop-
sies of human antrum and corpus of healthy volunteers. (Upper
panel) Autoradiogram of Western blot for ecNOS expression at
the protein level in gastric mucosal biopsies. (Lower panel)
Quanti¢cation of ecNOS protein, 160 Wg of protein loaded per
lane of gel (mean þ S.E.M., n = 6). A, antrum; CP, corpus; BE,
bovine endothelial cells (positive control), 20 Wg of protein
loaded. Abscissa: tissue; ordinate: pixels (arbitrary Phosphor-
Imager units) of ecNOS expression.
Fig. 8. Immunohistochemical detection of ecNOS in the fundus of human stomach. Photograph of alkaline phosphatase-stained frozen
section. Magni¢cation: U400.
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tion of the constitutive isoforms (bNOS and ecNOS)
of NO synthase in the gastrointestinal tract. Using a
monoclonal antibody against ecNOS originally de-
scribed by Pollock et al. [23], we noted a single
band at about 140 kDa in homogenates of di¡erent
gastrointestinal tissues of the rat and in surgical
specimens and biopsies of human esophagus and hu-
man stomach. There are several arguments speaking
in favor of the speci¢city of the signal obtained. The
apparent molecular mass of the signal of approxi-
mately 140 kDa and the fact that it comigrated
with the band in homogenates of endothelial cells
serving as a positive control strongly suggest the sig-
nal to represent ecNOS. In rat gastrointestinal tissue
expression of ecNOS protein did not di¡er between
stomach, colon and esophagus, but was lower in ho-
mogenates of rat ileum. Expression of ecNOS was
also noted in human stomach.
ecNOS expression in gastric mucosal biopsies of
human antrum was higher than in those of the cor-
pus. To our knowledge, this is the ¢rst report on
quanti¢cation of ecNOS in the human gastrointesti-
nal tract at the protein level and the ¢rst report on
altered regional di¡erences in the GI tract of any
species. It is tempting to speculate that enhanced
antral ecNOS expression may have some physiolog-
ical impact, e.g., in terms of mucosal protection by
increasing microcirculation.
The fact that positive ecNOS immunoreactivity
was encountered in the arteries and veins of human
gastric wall and was located mainly in endothelial
cells is consistent with the hypothesis that ecNOS is
involved in the regulation of gastric microcirculation.
To the best of our knowledge, this has not been
reported before.
From comparative studies there is morphological
evidence for a decrease in the number of vessels from
pylorus to fundus [24]. However, using laser Doppler
£owmetry we have found only a small di¡erence in
mucosal blood £ow between corpus and antrum [25].
Therefore, although these functional data have to be
interpreted with caution, it can be speculated that the
higher ecNOS expression in human antrum partially
compensates for the lesser number of vessels.
The relatively low ecNOS expression in rat ileum
might be due either to a reduced number of vessels or
lower protein expression per endothelial cell in that
tissue. It remains to be elucidated whether ecNOS
expression in human ileum is also lower than in other
parts of the human GI tract.
Since a blocking peptide was not available, a
blocking experiment for the Western blot and an
absorption control for immunohistochemistry could
not be performed. However, in immunohistochemis-
try only weak unspeci¢c binding (reaction remaining
positive in control without the ¢rst antibody) of link
antibody was noticed. The speci¢city of the bNOS
signal in Western blot is based on its apparent mo-
lecular mass of approximately 160 kDa and the fact
that it comigrated with recombinant rat neuronal
bNOS and rat cerebellum bNOS both used as pos-
itive controls. Up to now, the role of bNOS in gas-
trointestinal motility has been investigated solely by
the use of NO synthase inhibitors and by immuno-
histochemistry. Using the arginine/citrulline assay,
Salter et al. [5] reported high levels of Ca2-depend-
ent (constitutive) NO synthase activity in the stom-
ach of rats and humans, but a di¡erentiation be-
tween both isoforms (bNOS and ecNOS) was not
performed and no other tissues were analyzed. Re-
cently, bNOS expression at the protein and RNA
level were determined in rat brain, rat stomach, rat
rectum and rat spleen before and after treatment
with interferon-Q and VIP [26]. However, bNOS ex-
pression in rat esophagus, rat ileum and rat colon as
well as ecNOS expression in any tissue were not an-
alyzed by these authors.
In our study, we found the highest bNOS expres-
sion in rat esophagus, followed by colon, stomach
and ileum. Since rat esophagus is composed of stri-
ated muscle, the function of bNOS in this tissue has
not yet been determined. In the other parts of the GI
tract of the rat bNOS expression might re£ect the
importance of NO generated by bNOS as a messen-
ger of non-adrenergic non-cholinergic signal trans-
mission in this tissues. Furthermore, there is evidence
that bNOS is located in the surface cells of rat gastric
mucosa and might act as an intra- and intercellular
messenger to regulate mucus release [27].
Moreover, we could detect bNOS at the protein
level in biopsies and surgical specimens of human
esophagus and stomach. The relatively high amounts
of loaded protein might re£ect a lower expression of
bNOS in human gastrointestinal tract as compared
to rat, or could be due to a lower a⁄nity of the
antibody to human bNOS. Therefore, comparison
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between the di¡erent species on a (semi)-quantitative
level seems to be di⁄cult. Immunohistochemistry of
human gastric fundus revealed that bNOS expression
was located solely in the neuronal cells, but not in
smooth muscle, which is in agreement with previous
work [20].
In this study we present a method for the detection
and quanti¢cation of bNOS and ecNOS at the pro-
tein level in rat and human GI tract. One advantage
of this method might be due to the method of pro-
tein extraction: in initial experiments we used Tris^
HCl as extraction bu¡er, and noted that an increased
yield of protein can be achieved employing NaHCO3/
5% SDS instead of Tris and a microdismembrator
system instead of a polytron.
Obviously, the method of bNOS and ecNOS quan-
ti¢cation described here will allow investigation of
the role of these constitutive enzymes in physiologi-
cal and pathophysiological conditions of the rat and
human GI tract.
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